These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22072169)

  • 1. Hypnosedative access and risk of harm.
    Menkes DB; Shieffelbien LM; Huthwaite M
    N Z Med J; 2011 Nov; 124(1345):69-73. PubMed ID: 22072169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of PHARMAC's National Hospital Pharmaceutical Strategy on Quality Use of Medicines activities in New Zealand hospitals.
    Tordoff J; Norris P; Kennedy J; Reith D
    N Z Med J; 2006 Aug; 119(1239):U2100. PubMed ID: 16912718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytics and sedatives and risk of fractures: effects of half-life.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 Jan; 82(1):34-43. PubMed ID: 18175030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypnotics-sedatives and anxiolytics].
    Agustí Maragall C
    Rev Enferm; 1981 Jul; 4(37):55-60. PubMed ID: 6118933
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use.
    Kunac DL; Harrison-Woolrych M; Tatley MV
    N Z Med J; 2008 Oct; 121(1283):76-89. PubMed ID: 18841188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance in Europe and North America: divergent approaches.
    Wiktorowicz M; Lexchin J; Moscou K
    Soc Sci Med; 2012 Jul; 75(1):165-70. PubMed ID: 22521677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reducing the use of addictive drugs in clinical practice].
    Jørgensen VR; Toft BS; Fogh Mv
    Ugeskr Laeger; 2006 Apr; 168(17):1636-40. PubMed ID: 16674874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Addictive drugs are not for weaklings].
    Nessa J
    Tidsskr Nor Laegeforen; 2004 Sep; 124(18):2341. PubMed ID: 15467794
    [No Abstract]   [Full Text] [Related]  

  • 10. Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.
    Pharoah PD; Melzer D
    Br J Gen Pract; 1995 Nov; 45(400):595-9. PubMed ID: 8554839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population.
    Hausken AM; Skurtveit S; Tverdal A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):913-8. PubMed ID: 17486666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiolytic agents and hypnotic drugs in Bretagne. Pharmaco-epidemiological study].
    Nguyen JM; Allain H; Martinet JP; Beneton C; Reymann JM; Decombe R
    Ann Med Interne (Paris); 1991; 142(3):163-7. PubMed ID: 1677240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Premedication before endoscopic interventions: who is responsible?].
    Madler C
    Bildgebung; 1993 Apr; 60 Suppl 1():65-6. PubMed ID: 8104064
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Is it the crime of the century?': factors for psychiatrists and service users that influence the long-term prescription of hypnosedatives.
    MacDonald J; Garvie C; Gordon S; Huthwaite M; Mathieson F; Wood AJ; Romans S
    Int Clin Psychopharmacol; 2015 Jul; 30(4):193-201. PubMed ID: 25918885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of hypnotics in geriatric institutions in Hordaland and Sogn and Fjordane].
    Schjøtt J; Eide E
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1068-9. PubMed ID: 12760224
    [No Abstract]   [Full Text] [Related]  

  • 16. Altering intensive care sedation paradigms to improve patient outcomes.
    Riker RR; Fraser GL
    Crit Care Clin; 2009 Jul; 25(3):527-38, viii-ix. PubMed ID: 19576528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anxiety disorders in the Finnish general population.
    Sihvo S; Hämäläinen J; Kiviruusu O; Pirkola S; Isometsä E
    J Affect Disord; 2006 Nov; 96(1-2):31-8. PubMed ID: 16797721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary sedation practice in a large New Zealand emergency department.
    Harvey M; Cave G; Betham C
    N Z Med J; 2011 Oct; 124(1344):36-45. PubMed ID: 22016162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of respiratory and sleep services in New Zealand undertaken by the Thoracic Society of Australia and New Zealand (TSANZ).
    Garrett J; Chen B; Taylor DR
    N Z Med J; 2009 Feb; 122(1289):10-23. PubMed ID: 19305445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed?
    Alla F; Rosilio M; Funck-Brentano C; ; Barthélémy P; Brisset S; Cellier D; Chassany O; Demarez JP; Diebolt V; Francillon A; Gambotti L; Hannachi H; Lechat P; Lemaire F; Lièvre M; Misse C; Nguon M; Pariente A; Rosenheim M; Weisslinger-Darmon N
    Therapie; 2013; 68(4):209-23. PubMed ID: 23981258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.